Effect of dietary fiber intake on lipoprotein cholesterol levels independent of estradiol in healthy premenopausal women

American Journal of Epidemiology

Volumn 173, Issue 2, 2011, Pages 145-156

  Mumford, Sunni L ^a,b   Schisterman, Enrique F ^a   Siega Riz, Anna Maria ^b,c   Gaskins, Audrey J ^a   Wactawski Wende, Jean ^d   Vanderweele, Tyler J ^e  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b IL   (United States)

^c University of North Carolina   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

cholesterol; dietary fiber; estradiol; lipoproteins; menstrual cycle

Indexed keywords

ALPHA TOCOPHEROL; ESTRADIOL; FOLLITROPIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; PROGESTERONE;

BODY MASS; COHORT ANALYSIS; DIETARY SHIFT; ENERGY EFFICIENCY; HORMONE; LIPID; NUMERICAL MODEL; PROTEIN; RESEARCH WORK; VITAMIN; WOMENS HEALTH;

ADULT; ARTICLE; COHORT ANALYSIS; DIETARY FIBER; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; MENSTRUAL CYCLE; NORMAL HUMAN; PHYSICAL ACTIVITY; PILOT STUDY; PREMENOPAUSE; PROSPECTIVE STUDY; VITAMIN INTAKE;

ADOLESCENT; ADULT; CHOLESTEROL; DIETARY FIBER; ESTRADIOL; FEMALE; HUMANS; LINEAR MODELS; LIPOPROTEINS; MENSTRUAL CYCLE; PROSPECTIVE STUDIES; YOUNG ADULT;

NEW YORK [NEW YORK (STT)]; NEW YORK [UNITED STATES]; UNITED STATES;

EID: 78650658262     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq388     Document Type: Article

References (54)

1. Anderson JW, Baird P, Davis RH Jr, et al. Health benefits of dietary fiber. Nutr Rev. 2009;67(4):188-205.
2. Brown L, Rosner B, Willett WW, et al. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999; 69(1):30-42.
3. Fernandez ML. Soluble fiber and nondigestible carbohydrate effects on plasma lipids and cardiovascular risk. Curr Opin Lipidol. 2001;12(1):35-40.
4. Kritchevsky D. Dietary fibre and lipid metabolism. Int J Obes. 1987;11(suppl 1):33-43.
5. Lipsky H, Gloger M, Frishman WH. Dietary fiber for reducing blood cholesterol. J Clin Pharmacol. 1990;30(8):699-703.
6. Mozaffarian D, Kumanyika SK, Lemaitre RN, et al. Cereal, fruit, and vegetable fiber intake and the risk of cardiovascular disease in elderly individuals. JAMA. 2003;289(13):1659-1666.
7. Stampfer MJ, Hu FB, Manson JE, et al. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000;343(1):16-22.
8. Jenkins DJ, Kendall CW, Vuksan V. Viscous fibers, health claims, and strategies to reduce cardiovascular disease risk. Am J Clin Nutr. 2000;71(2):401-402.
9. Kay RM. Effects of dietary fibre on serum lipid levels and fecal bile acid excretion. Can Med Assoc J. 1980;123(12): 1213-1217.
10. Marlett JA, Hosig KB, Vollendorf NW, et al. Mechanism of serum cholesterol reduction by oat bran. Hepatology. 1994; 20(6):1450-1457.
11. Bagga D, Ashley JM, Geffrey SP, et al. Effects of a very low fat, high fiber diet on serum hormones and menstrual function. Implications for breast cancer prevention. Cancer. 1995; 76(12):2491-2496.
12. Gaskins AJ, Mumford SL, Zhang C, et al. Effect of daily fiber intake on reproductive function: the BioCycle Study. Am J Clin Nutr. 2009;90(4):1061-1069.
13. Gann PH, Chatterton RT, Gapstur SM, et al. The effects of a low-fat/high-fiber diet on sex hormone levels and menstrual cycling in premenopausal women: a 12-month randomized trial (the Diet and Hormone Study). Cancer. 2003;98(9): 1870-1879.
14. Goldin BR, Woods MN, Spiegelman DL, et al. The effect of dietary fat and fiber on serum estrogen concentrations in pre-menopausal women under controlled dietary conditions. Cancer. 1994;74(suppl 3):1125-1131.
15. Kaneda N, Nagata C, Kabuto M, et al. Fat and fiber intakes in relation to serum estrogen concentration in premenopausal Japanese women. Nutr Cancer. 1997;27(3):279-283.
16. Rose DP, Goldman M, Connolly JM, et al. High-fiber diet reduces serum estrogen concentrations in premenopausal women. Am J Clin Nutr. 1991;54(3):520-525.
17. Aubertin-Leheudre M, Gorbach S, Woods M, et al. Fat/fiber intakes and sex hormones in healthy premenopausal women in USA. J Steroid Biochem Mol Biol. 2008;112(1-3):32-39.
18. Woods MN, Barnett JB, Spiegelman D, et al. Hormone levels during dietary changes in premenopausal African-American women. J Natl Cancer Inst. 1996;88(19):1369-1374.
19. Wu AH, Pike MC, Stram DO. Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst. 1999;91(6):529-534.
20. Ganji V, Kuo J. Serum lipid responses to psyllium fiber: differences between pre- and post-menopausal, hypercholes-terolemic women. Nutr J. 2008;7:22. (doi: 10.1186/1475-2891-7-22).
21. Vega-López S, Vidal-Quintanar RL, Fernandez ML. Sex and hormonal status influence plasma lipid responses to psyllium. Am J Clin Nutr. 2001;74(4):435-441.
22. 2-isoprostane levels in premenopausal women: the BioCycle Study. Am J Epidemiol. 2010;172(4):430-439.
23. Wactawski-Wende J, Schisterman EF, Hovey KM, et al. Bio-Cycle Study: design of the longitudinal study of the oxidative stress and hormone variation during the menstrual cycle. Paediatr Perinat Epidemiol. 2009;23(2):171-184.
24. Howards PP, Schisterman EF, Wactawski-Wende J, et al. Timing clinic visits to phases of the menstrual cycle by using a fertility monitor: the BioCycle Study. Am J Epidemiol. 2009; 169(1):105-112.
25. Patterson RE, Kristal AR, Tinker LF, et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol. 1999;9(3):178-187.
26. Subar AF, Kipnis V, Troiano RP, et al. Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study. Am J Epidemiol. 2003;158(1): 1-13.
27. Schatzkin A, Kipnis V, Carroll RJ, et al. A comparison of a food frequency questionnaire with a 24-hour recall for use in an epidemiological cohort study: results from the biomarker-based Observing Protein and Energy Nutrition (OPEN) study. Int J Epidemiol. 2003;32(6):1054-1062.
28. Browne RW, Bloom MS, Schisterman EF, et al. Analytical and biological variation of biomarkers of oxidative stress during the menstrual cycle. Biomarkers. 2008;13(2):160-183.
29. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502.
30. Craig CL, Marshall AL, Sjöström M, et al. International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381-1395.
31. Petersen ML, Sinisi SE, van der Laan MJ. Estimation of direct causal effects. Epidemiology. 2006;17(3):276-284.
32. Rible RD, Taylor D, Wilson ML, et al. Follicular development in a 7-day versus 4-day hormone-free interval with an oral contraceptive containing 20 mcg ethinyl estradiol and 1 mg norethindrone acetate. Contraception. 2009;79(3):182-188.
33. Rexrode KM, Manson JE, Lee IM, et al. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation. 2003;108(14):1688- 1693.
34. Birtch RL, Olatunbosun OA, Pierson RA. Ovarian follicular dynamics during conventional vs. continuous oral contraceptive use. Contraception. 2006;73(3):235-243.
35. Vandever MA, Kuehl TJ, Sulak PJ, et al. Evaluation of pituitary-ovarian axis suppression with three oral contraceptive regimens. Contraception. 2008;77(3):162-170.
36. Bland JM, Altman DG. Multiple significance tests: the Bon-ferroni method. BMJ. 1995;310(6973):170.
37. VanderWeele TJ. Marginal structural models for the estimation of direct and indirect effects. Epidemiology. 2009;20(1): 18-26.
38. Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11(5):550-560.
39. Cole SR, Hernán MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008; 168(6):656-664.
40. Robins JM, Greenland S. Identifiability and exchangeability for direct and indirect effects. Epidemiology. 1992;3(2):143-155.
41. VanderWeele TJ. Bias formulas for sensitivity analysis for direct and indirect effects. Epidemiology. 2010;21(4): 540-551.
42. Adlercreutz H, Tallqvist G. Variations in the serum total cholesterol and hematocrit values in normal women during the menstrual cycle. Scand J Clin Lab Invest. 1959;11(1):1-9.
43. Cullinane EM, Yurgalevitch SM, Saritelli AL, et al. Variations in plasma volume affect total and low-density lipoprotein cholesterol concentrations during the menstrual cycle. Metabolism. 1995;44(8):965-971.
44. Pahwa MB, Seth S, Seth RK. Lipid profile in various phases of menstrual cycle and its relationship with percentage plasma volume changes. Clin Chim Acta. 1998;273(2):201-207.
45. Institute of Medicine of the National Academies. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids. Washington, DC: National Academies Press; 2002.
46. Frankenfield D, Roth-Yousey L, Compher C. Comparison of predictive equations for resting metabolic rate in healthy nonobese and obese adults: a systematic review. J Am Diet Assoc. 2005;105(5):775-789.
47. Goldin BR, Adlercreutz H, Gorbach SL, et al. Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. N Engl J Med. 1982;307(25):1542-1547.
48. Knopp RH, Paramsothy P, Retzlaff BM, et al. Sex differences in lipoprotein metabolism and dietary response: basis in hormonal differences and implications for cardiovascular disease. Curr Cardiol Rep. 2006;8(6):452-459.
49. LaRosa JC. Women, lipoproteins and cardiovascular disease risk. Can J Cardiol. 1990;6(suppl B):23B-29B.
50. Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 2003; 349(6):523-534.
51. Kaufman JS, MacLehose RF, Kaufman S. A further critique of the analytic strategy of adjusting for covariates to identify biologic mediation. Epidemiol Perspect Innov. 2004;1(1):4. (doi: 10.1186/1742-5573-1-4). (Pubitemid 40404935)
52. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:200-202, 545-546.
53. Susser M. Causal Thinking in the Health Sciences: Concepts and Strategies in Epidemiology. New York, NY: Oxford University Press; 1973:121-124.
54. Szklo M, Nieto FJ. Epidemiology: Beyond the Basics. Gai-thersburg, MD: Aspen Publishers; 2000:184-187.